Bennicas & Associates, Inc. Elanco Animal Health Inc Transaction History

Bennicas & Associates, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	SELL	$12.41 - $32.42 $9,928 - $25,936	-800 Reduced 4.95%	15,353 $191,000
Q2 2022 Jul 12, 2022	SELL	$19.63 - $26.62 $3,003 - $4,072	-153 Reduced 0.94%	16,153 $317,000
Q4 2021 Jan 14, 2022	BUY	$27.74 - $34.09 $14,868 - $18,272	536 Added 3.4%	16,306 $463,000
Q3 2021 Oct 08, 2021	SELL	$29.2 - $36.72 $58 - $73	-2 Reduced 0.01%	15,770 $503,000
Q1 2021 Apr 15, 2021	BUY	$27.85 - $34.49 $209,209 - $259,088	7,512 Added 90.94%	15,772 $464,000
Q4 2020 Jan 15, 2021	BUY	$27.53 - $33.79 $227,397 - $279,105	8,260 New	8,260 $253,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.42B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Bennicas & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Bennicas & Associates, Inc. with notifications on news.